Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Clinical Nuclear Medicine|April 29, 2025
Superior NET Targeting by Switch From Agonist to Antagonist-mediated Somatostatin Receptor Theranostics Allowing Successful (LM3-based) PRRT of Otherwise Precluded mNET: Intraindividual Proof-of-conceptTilman Speicher, Caroline Burgard, Florian Rosar, et al.
Radiation Oncology (London, England)|January 27, 2012
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBGSamer Ezziddin, Amir Sabet, Yon-Dschun Ko, et al.
Clinical Nuclear Medicine|April 30, 2025
Superior Response of CAP-PRRT of G3 NET When Switching to the Somatostatin Receptor Antagonist LM3: Intraindividual Proof-of-conceptTilman Speicher, Caroline Burgard, Florian Rosar, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotateAmir Sabet, Feras Khalaf, Soha Mahjoob, et al.
Clinical Nuclear Medicine|December 3, 2024
First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3)Tilman Speicher, Caroline Burgard, Moritz Bastian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2013
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumoursCarsten Meyer, Claus Christian Pieper, Samer Ezziddin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 2, 2011
99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolizationHojjat Ahmadzadehfar, Amir Sabet, Marianne Muckle, et al.
Parkinsonism & Related Disorders|May 13, 2018
MIBG scintigraphy of the major salivary glands in multiple system atrophyLuisa Soboll, Daniela Leppert, Ulrich Dillmann, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 30, 2026
FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?Moritz B Bastian, Ionas Kyriakou, Florian Rosar, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [<sup>18</sup>F]FDG PET/CTMoritz B Bastian, Arne Blickle, Caroline Burgard, et al.
Pageof 16